Health · Public Health & Disease · 19 hrs ago
Study finds flu vaccine protection often below commonly cited range
A University of Maryland study found flu vaccines often protect less than expected against infection.
Researchers examined vaccine effectiveness at the end of each season from 2004–05 through 2023–24.
Across those seasons, median effectiveness was 39.5%, below the 40% to 60% range often cited by health officials.
The vaccine did not match circulating flu strains in 11 of the 18 seasons assessed for strain match.
Researchers said this does not mean people should stop getting vaccinated; the CDC estimated vaccination saved 7,900 lives in 2023–24 and prevented 120,000 flu-related hospitalizations.
Researchers want more reliable, longer-lasting vaccines, while annual flu shots remain the best available protection against the virus.
A University of Maryland study found that flu vaccines had a median effectiveness of 39.5% against infection across the seasons it examined.
The finding is below the 40% to 60% effectiveness range commonly cited by health officials and media.
Vaccines did not match circulating flu strains in 11 of the 18 seasons studied.
Researchers said the findings do not mean people should stop getting vaccinated.
They described annual vaccination as the best available option while researchers work to develop more predictable, longer-lasting protection.
- Who
- Researchers from the University of Maryland conducted the study.
- What
- The study found median flu vaccine effectiveness against infection was 39.5%, below the commonly cited 40% to 60% range.
- When
- The analysis covered flu seasons from 2004-2005 through 2023-2024. It was published in JAMA Network Open on November 10, 2026.
- Where
- University of Maryland; the study examined flu seasons without specifying a location for them.
- Why
- The researchers examined vaccine effectiveness and whether each season’s vaccine matched circulating strains.
This story does not have two clearly opposing sides.
The researchers examined end-of-season vaccine effectiveness estimates and whether vaccines matched circulating strains.
The study was published in JAMA Network Open.
The University of Maryland School of Medicine issued a press release about the findings.
Infobae and Medical Xpress published reports on the study.
- Median effectiveness
- 39.5% against flu infection
- Commonly cited effectiveness
- 40% to 60%
- Seasons studied
- 18, from 2004-2005 through 2023-2024
- Vaccine-strain mismatch
- 11 of 18 seasons
- Study journal
- JAMA Network Open
2 sources
What people are saying
Although the 40-60% range might describe some seasons, it does not adequately reflect the variability we observe over time.
communicate that uncertainty without losing sight of the important benefits of vaccination.
The message is clear: for now, annual flu vaccines remain our best option as we continue to develop vaccines that offer more predictable and longer-lasting protection.